Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrarosa for Recurrent UTIs in Postmenopausal Women
NCT03854396Phase 3Withdrawn
- Start
- May 2020
- Primary completion
- Feb 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in urinary tract infection (UTI). Planned start May 2020; status: withdrawn.
02
Drugs
dehydroepiandrosterone
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03854396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854396.